Search Within

Xiaoli Mi

Formats
  1. Journal Article (7)
  2. Meeting Abstract (6)
  3. Research Letter (3)
Groups
  1. GME, Medicine (16)
  2. Graduate Medical Education (16)
  3. Hematology-Oncology Fellows (16)
  4. Center for Hematologic Malignancies (15)
  5. Department of Medicine (15)
  6. Hematologic Malignancies, Division of (15)

More Groups

People
  1. Omar Abdel-Wahab (14)
  2. Alexander Penson (7)
  3. Simon Hogg (5)
  4. Caroline Erickson (4)
  5. Eric Wang (4)
  6. Eytan Stein (4)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (5)
  4. 2022 (3)
  5. 2021 (1)
  6. 2020 (3)
Publications
  1. Blood (7)
  2. Leukemia (2)
  3. New England Journal of Medicine (2)
  4. Cancer Immunology Research (1)
  5. JCO Precision Oncology (1)
  6. Nature Cancer (1)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. Massachusetts Medical Society (2)
  3. Nature Publishing Group (2)
  4. American Association for Cancer Research (1)
  5. American Association for the Advancement of Science (1)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (16)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced splicing factor-mutant myeloid malignancies
    Research Letter

    Bewersdorf, J. P.; Mi, X.; Lu, B.; Kuykendall, A.; Sallman, D.; Patel, M.; Stevens, D.; Philipovskiy, A.; Sutamtewagul, G.; Masarova, L.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Phase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with relapsed or refractory, splicing factor-mutant myeloid malignancies
    Meeting Abstract

    Bewersdorf, J. P.; Mi, X.; Lu, B.; Kuykendall, A. T.; Sallman, D.; Patel, M.; Stevens, D. A.; Philipovskiy, A.; Sutamtewagul, G.; Masarova, L.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Augmenting CAR T-cell functions with LIGHT
    Journal Article

    Cai, W.; Tanaka, K.; Mi, X.; Rajasekhar, V. K.; Khan, J. F.; Yoo, S.; de Stanchina, E.; Rahman, J.; Mathew, S.; Abrahimi, P.; more...
    Cancer Immunology Research (2024)

    Fulltext@MSK | Save
  • Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127
    Journal Article

    Montoya, S.; Bourcier, J.; Noviski, M.; Lu, H.; Thompson, M. C.; Chirino, A.; Jahn, J.; Sondhi, A. K.; Gajewski, S.; Tan, Y. S.; more...
    Science (2024)

    Fulltext@MSK | Save
  • Molecular attributes of CAR T cell fitness in patients with chronic lymphocytic leukemia
    Meeting Abstract

    Mi, X.; Yuan, D.; Murray, R.; Huuhtanen, J.; Zhang, B.; Quentin, J.; Shestova, O.; Porter, D. L.; Mustjoki, S.; Gill, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Genetic basis of relapse after GPRC5D-targeted CAR T cells
    Meeting Abstract

    Mi, X.; Penson, A.; Abdel-Wahab, O.; Mailankody, S.
    Blood (2023)

    Fulltext@MSK | Save
  • Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia
    Journal Article

    Knorr, K.; Rahman, J.; Erickson, C.; Wang, E.; Monetti, M.; Li, Z.; Ortiz-Pacheco, J.; Jones, A.; Lu, S. X.; Stanley, R. F.; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: A phase II clinical trial
    Research Letter

    Bewersdorf, J. P.; Stahl, M.; Taylor, J.; Mi, X.; Chandhok, N. S.; Watts, J.; Derkach, A.; Wysocki, M.; Lu, S. X.; Bourcier, J.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • Genetic basis of relapse after GPRCSD-targeted CAR T cells
    Research Letter

    Mi, X.; Penson, A.; Abdel-Wahab, O.; Mailankody, S.
    New England Journal of Medicine (2023)

    Fulltext@MSK | Save
  • Systematic evaluation of AML-associated antigens identifies novel anti-U5 snRNP200 therapeutic antibodies for the treatment of AML
    Meeting Abstract

    Knorr, K.; Erickson, C.; Wang, E.; Rahman, J.; Mi, X.; Lu, S.; Fox, N.; Penson, A.; Hogg, S.; Stanley, R.; more...
    Blood (2022)

    Fulltext@MSK | Save